43 results on '"Dauplat, Marie Mélanie"'
Search Results
2. When to do surgical resection for atypical breast lesions: Results of a prospective cohort of 518 lesions
3. Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein
4. Lésions histologiques mammaires à risque : classification actuelle et prise en charge
5. Supplementary Fig. S1 from Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept
6. Data from Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept
7. Supplementary Figure Legends from Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept
8. Supplementary Table S1 from Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept
9. Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma
10. Small rigid platforms functionalization with quaternary ammonium: Targeting extracellular matrix of chondrosarcoma
11. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France
12. Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014
13. 99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
14. Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies
15. Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion
16. Embolization and Endothelial Ablation With Chitosan and Sodium Sotradecol Sulfate: Preliminary Results in an Animal Model
17. When to do surgical resection for atypical breast lesions: Results of a prospective cohort of 518 lesions
18. Recommandations du GEFPICS pour la prise en charge des prélèvements dans le cadre du traitement néoadjuvant du cancer du sein
19. TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer
20. Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept
21. Étude de la marque H3K27me3 à l’échelle du génome : mise en place d’un profil épigénétique en fonction de l’agressivité du cancer de la prostate
22. Molecular and Epigenetic Biomarkers in Luminal Androgen Receptor: A Triple Negative Breast Cancer Subtype
23. Mécanismes moléculaires de la surexpression de hTERT dans le cancer du sein
24. Abstract 550: Genomic instability and telomere characteristics as predictive biomarkers of therapeutic response in triple-negative breast cancer
25. Cetuximab in combination with docetaxel (T) in patients with operable, triple-negative breast cancer (TNBC): Preliminary results of a multicentre neoadjuvant pilot phase II study.
26. Relevance of the POS-1 Orthotopic Model as an “Imaging Model” for In Vivo and Simultaneous Monitoring of Tumor Proliferation and Bone Remodeling in Osteosarcoma
27. Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies
28. A “Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model
29. 19: Développement d’une stratégie innovante de vectorisation d’agents diagnostiques et thérapeutiques vers les protéoglycanes du chondrosarcome
30. Pièges diagnostiques en pathologie mammaire. Cas no 8. Métastases mammaires d’un mélanome malin
31. Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2 + γδ T Cell Alterations with Lymph Node Invasion.
32. Mécanismes moléculaires de la surexpression de hTERTdans le cancer du sein
33. [2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France].
34. [GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting].
35. Molecular and Epigenetic Biomarkers in Luminal Androgen Receptor: A Triple Negative Breast Cancer Subtype.
36. [Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].
37. [2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].
38. [Diagnostic approach for breast cancer classification].
39. A"Proteoglycan targeting strategy" for the scintigraphic imaging and monitoring of the swarm rat chondrosarcoma orthotopic model.
40. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
41. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
42. [An aggressive subtype of breast carcinoma].
43. [An inflammatory tumor-like lesion of the breast].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.